Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2006 Filed Jan 3, 2007 23:25 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 1,586 | $25.90 | $41,077.40 |
DisclosureSEC source: 0000078003-07-000007 · kin1408.xml · nonDerivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,446 Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:26 UTC |
MCKINNELL HENRY ADirector
|
GrantPhantom Stock Units SSP · Derivative | 154 | $25.90 | $3,988.60 |
DisclosureSEC source: 0000078003-07-000010 · mck1410.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,099 Underlying: Common Stock · 154 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:25 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 200 | $25.90 | $5,180.00 |
DisclosureSEC source: 0000078003-07-000008 · lam1409.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,161 Underlying: Common Stock · 200 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:25 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 307 | $25.90 | $7,951.30 |
DisclosureSEC source: 0000078003-07-000009 · lev1418.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,819 Underlying: Common Stock · 307 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:26 UTC |
MONTERO SYLVIA MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 37 | $25.90 | $958.30 |
DisclosureSEC source: 0000078003-07-000011 · mon1411.xml · derivative · entry 1 MONTERO SYLVIA M · CIK 0001372912 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,980 Underlying: Common Stock · 37 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:26 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 144 | $25.90 | $3,729.60 |
DisclosureSEC source: 0000078003-07-000012 · rea1412.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,791 Underlying: Common Stock · 144 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:26 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 310 | $25.90 | $8,029.00 |
DisclosureSEC source: 0000078003-07-000013 · she1413.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,601 Underlying: Common Stock · 310 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 29, 2006 Filed Jan 3, 2007 23:26 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 47 | $25.90 | $1,217.30 |
DisclosureSEC source: 0000078003-07-000014 · wax1414.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,325 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 22, 2006 Filed Dec 22, 2006 16:03 UTC |
STEERE WILLIAM C JRDirector
|
GiftCommon Stock | 99,998 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000353 · ste1404.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,690,090 Read SEC document |
| December 19, 2006 Filed Dec 20, 2006 16:18 UTC |
LEVIN ALAN GSenior Vice President
|
GiftCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000351 · lev1403.xml · nonDerivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,188 Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 40 | $25.64 | $1,025.60 |
DisclosureSEC source: 0000078003-06-000340 · bag1391.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,766 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 49 | $25.64 | $1,256.36 |
DisclosureSEC source: 0000078003-06-000341 · can1392.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 Underlying: Common Stock · 49 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 80 | $25.64 | $2,051.20 |
DisclosureSEC source: 0000078003-06-000342 · fec1393.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,872 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
KINDLER JEFFREY BDirector · Chief Executive Officer
|
GrantPhantom Stock Units SSP · Derivative | 112 | $25.64 | $2,871.68 |
DisclosureSEC source: 0000078003-06-000343 · kin1394.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,573 Underlying: Common Stock · 112 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 272 | $25.64 | $6,974.08 |
DisclosureSEC source: 0000078003-06-000344 · lam1395.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,961 Underlying: Common Stock · 272 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
MCKINNELL HENRY ADirector · Chairman of the Board
|
GrantPhantom Stock Units SSP · Derivative | 299 | $25.64 | $7,666.36 |
DisclosureSEC source: 0000078003-06-000346 · mck1397.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,945 Underlying: Common Stock · 299 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 389 | $25.64 | $9,973.96 |
DisclosureSEC source: 0000078003-06-000345 · lev1396.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,512 Underlying: Common Stock · 389 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:46 UTC |
MONTERO SYLVIA MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $25.64 | $1,153.80 |
DisclosureSEC source: 0000078003-06-000347 · mon1398.xml · derivative · entry 1 MONTERO SYLVIA M · CIK 0001372912 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,943 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:47 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 187 | $25.64 | $4,794.68 |
DisclosureSEC source: 0000078003-06-000348 · rea1399.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,647 Underlying: Common Stock · 187 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:47 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 423 | $25.64 | $10,845.72 |
DisclosureSEC source: 0000078003-06-000349 · she1400.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,291 Underlying: Common Stock · 423 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 13:47 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $25.64 | $1,333.28 |
DisclosureSEC source: 0000078003-06-000350 · wax1401.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,278 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| December 12, 2006 Filed Dec 12, 2006 21:45 UTC |
MCKINNELL HENRY ADirector · Chairman of the Board
|
GiftCommon Stock | 10,330 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000338 · mck1390.xml · nonDerivative · entry 2 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,933,928 Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 21:45 UTC |
MCKINNELL HENRY ADirector · Chairman of the Board
|
GiftCommon Stock | 1,030 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000338 · mck1390.xml · nonDerivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,944,258 Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 19:52 UTC |
Ausiello Dennis ADirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000333 · aus1389.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 33 | $27.49 | $907.17 |
DisclosureSEC source: 0000078003-06-000320 · bag1378.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,726 Underlying: Common Stock · 33 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 36 | $27.49 | $989.64 |
DisclosureSEC source: 0000078003-06-000321 · can1379.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 43 | $27.49 | $1,182.07 |
DisclosureSEC source: 0000078003-06-000322 · fec1380.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,792 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
KINDLER JEFFREY BDirector · Chief Executive Officer
|
GrantPhantom Stock Units SSP · Derivative | 88 | $27.49 | $2,419.12 |
DisclosureSEC source: 0000078003-06-000323 · kin1381.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,461 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 172 | $27.49 | $4,728.28 |
DisclosureSEC source: 0000078003-06-000324 · lam1382.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,689 Underlying: Common Stock · 172 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 269 | $27.49 | $7,394.81 |
DisclosureSEC source: 0000078003-06-000325 · lev1383.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,123 Underlying: Common Stock · 269 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:23 UTC |
MCKINNELL HENRY ADirector · Chairman of the Board
|
GrantPhantom Stock Units SSP · Derivative | 116 | $27.49 | $3,188.84 |
DisclosureSEC source: 0000078003-06-000326 · mck1384.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,646 Underlying: Common Stock · 116 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:24 UTC |
MONTERO SYLVIA MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 34 | $27.49 | $934.66 |
DisclosureSEC source: 0000078003-06-000327 · mon1385.xml · derivative · entry 1 MONTERO SYLVIA M · CIK 0001372912 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,898 Underlying: Common Stock · 34 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:24 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 126 | $27.49 | $3,463.74 |
DisclosureSEC source: 0000078003-06-000328 · rea1386.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,460 Underlying: Common Stock · 126 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:24 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 265 | $27.49 | $7,284.85 |
DisclosureSEC source: 0000078003-06-000329 · she1387.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,868 Underlying: Common Stock · 265 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2006 Filed Dec 4, 2006 17:24 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 43 | $27.49 | $1,182.07 |
DisclosureSEC source: 0000078003-06-000330 · wax1388.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,226 Underlying: Common Stock · 43 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 59 | $26.53 | $1,565.27 |
DisclosureSEC source: 0000078003-06-000296 · bag1366.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,693 Underlying: Common Stock · 59 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 92 | $26.53 | $2,440.76 |
DisclosureSEC source: 0000078003-06-000297 · can1367.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,843 Underlying: Common Stock · 92 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 219 | $26.53 | $5,810.07 |
DisclosureSEC source: 0000078003-06-000298 · fec1368.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,749 Underlying: Common Stock · 219 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
KINDLER JEFFREY BDirector · Chief Executive Officer
|
GrantPhantom Stock Units SSP · Derivative | 187 | $26.53 | $4,961.11 |
DisclosureSEC source: 0000078003-06-000299 · kin1369.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,373 Underlying: Common Stock · 187 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 632 | $26.53 | $16,766.96 |
DisclosureSEC source: 0000078003-06-000300 · lam1370.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,517 Underlying: Common Stock · 632 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:18 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 792 | $26.53 | $21,011.76 |
DisclosureSEC source: 0000078003-06-000301 · lev1371.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,854 Underlying: Common Stock · 792 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:19 UTC |
MCKINNELL HENRY ADirector · Chairman of the Board
|
GrantPhantom Stock Units SSP · Derivative | 1,035 | $26.53 | $27,458.55 |
DisclosureSEC source: 0000078003-06-000302 · mck1372.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,530 Underlying: Common Stock · 1,035 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:19 UTC |
MONTERO SYLVIA MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 80 | $26.53 | $2,122.40 |
DisclosureSEC source: 0000078003-06-000303 · mon1373.xml · derivative · entry 1 MONTERO SYLVIA M · CIK 0001372912 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,864 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:19 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 396 | $26.53 | $10,505.88 |
DisclosureSEC source: 0000078003-06-000304 · rea1374.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,334 Underlying: Common Stock · 396 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:19 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 990 | $26.53 | $26,264.70 |
DisclosureSEC source: 0000078003-06-000305 · she1375.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,603 Underlying: Common Stock · 990 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2006 Filed Nov 16, 2006 22:19 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 73 | $26.53 | $1,936.69 |
DisclosureSEC source: 0000078003-06-000306 · wax1376.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,183 Underlying: Common Stock · 73 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 08, 2006 Filed Nov 13, 2006 15:09 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,448 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000078003-06-000295 · can1365.xml · derivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,052 Underlying: Common Stock · 5,448 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. Read SEC document |
| November 08, 2006 Filed Nov 13, 2006 15:09 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Tax withholdingCommon Stock | 3,782 | $26.44 | $99,996.08 |
DisclosureSEC source: 0000078003-06-000295 · can1365.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,856 Read SEC document |
| November 08, 2006 Filed Nov 13, 2006 15:09 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionCommon Stock | 5,448 | $18.35 | $99,970.80 |
DisclosureSEC source: 0000078003-06-000295 · can1365.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2006 Filed Nov 8, 2006 22:53 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 894,552 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000078003-06-000294 · ste1364.xml · derivative · entry 4 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 894,552 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.